WPG Advisers’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

WPG Advisers’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-380	Closed	-$50.1K	–	1514
2025 Q1	$50.1K	Sell	380 -52	-12%	-$6.48K	0.05%	268
2024 Q4	$36.1K	Buy	+432	New	+$35.5K	0.03%	349

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

WPG Advisers's ITCI Position: Q2 2025 in Review

WPG Advisers sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 380 shares — an estimated $50.1K sold.

WPG Advisers first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $50.1K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

WPG Advisers reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
WPG Advisers sold 380 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $50.1K.
WPG Advisers first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
WPG Advisers's Intra-Cellular Therapies Inc. position peaked at $50.1K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on WPG Advisers's 13F filing for Q2 2025, filed 11 Aug 2025.